Home Other Building Blocks 1-Phenylpiperazine hydrochloride

1-Phenylpiperazine hydrochloride

CAS No.:
2210-93-7
Catalog Number:
AG003EMS
Molecular Formula:
C10H15ClN2
Molecular Weight:
198.6925
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
1 week
United States
$121
- +
5g
1 week
United States
$150
- +
10g
1 week
United States
$212
- +
25g
1 week
United States
$334
- +
Product Description
Catalog Number:
AG003EMS
Chemical Name:
1-Phenylpiperazine hydrochloride
CAS Number:
2210-93-7
Molecular Formula:
C10H15ClN2
Molecular Weight:
198.6925
MDL Number:
MFCD00012758
IUPAC Name:
1-phenylpiperazine;hydrochloride
InChI:
InChI=1S/C10H14N2.ClH/c1-2-4-10(5-3-1)12-8-6-11-7-9-12;/h1-5,11H,6-9H2;1H
InChI Key:
NQNZNONJZASOKL-UHFFFAOYSA-N
SMILES:
N1CCN(CC1)c1ccccc1.Cl
EC Number:
218-646-9
Properties
Complexity:
124  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
198.092g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
198.694g/mol
Monoisotopic Mass:
198.092g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
15.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats. Neuropharmacology 20121201
DNA-binding, spectroscopic and antimicrobial studies of palladium(II) complexes containing 2,2'-bipyridine and 1-phenylpiperazine. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001
Phenylpiperazine derivatives: a patent review (2006 - present). Expert opinion on therapeutic patents 20121001
Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities. Bioorganic & medicinal chemistry 20120401
FT-IR and Raman spectroscopic and quantum chemical investigations of some metal halide complexes of 1-phenylpiperazine. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120301
Bivalent molecular probes for dopamine D2-like receptors. Bioorganic & medicinal chemistry 20120101
Synthesis and vibrational spectroscopic analysis of some Hofmann type clathrates. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111101
Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones. Bioorganic & medicinal chemistry letters 20111001
Sleep deprivation differentially affects dopamine receptor subtypes in mouse striatum. Neuroreport 20110713
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists. Journal of medicinal chemistry 20110414
Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice. Pharmacological reports : PR 20110101
Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin. Bioorganic & medicinal chemistry letters 20101015
Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry. Journal of chromatography. A 20101001
Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16). Journal of medicinal chemistry 20100325
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. Bioorganic & medicinal chemistry 20100301
[(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20091101
Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding. Journal of medicinal chemistry 20090813
Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases. Bioorganic & medicinal chemistry 20090701
Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist. Journal of medicinal chemistry 20090528
Application of a library of artificial receptors formed by the self-organization of N-lipidated peptides immobilized on cellulose in studying the effects of the incorporation of a fluorine atom. Journal of combinatorial chemistry 20090101
FT-IR spectroscopic investigation of some Hofmann type complexes: M(1-phenylpiperazine)2Ni(CN)4 (M=Ni, Co, Cd, Pd or Mn). Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080701
Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin. Bioorganic & medicinal chemistry 20080601
Determination of lipophilicity of alpha-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods. Biomedical chromatography : BMC 20080401
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581. Pharmacology, biochemistry, and behavior 20080301
Two new phenylpiperazines with atypical antipsychotic potential. Bioorganic & medicinal chemistry letters 20071101
FT-IR and NMR investigation of 1-phenylpiperazine: a combined experimental and theoretical study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070701
Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria. Chemical biology & drug design 20070401
Identification of metabolites produced from N-phenylpiperazine by Mycobacterium spp. Journal of industrial microbiology & biotechnology 20070301
Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives. Bioorganic & medicinal chemistry 20061115
Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors. Journal of medicinal chemistry 20060824
BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline. Bioorganic & medicinal chemistry letters 20060401
Binding and photocleavage of cationic porphyrin-phenylpiperazine hybrids to DNA. Biophysical chemistry 20060201
In vitro metabolism studies of (18)F-labeled 1-phenylpiperazine using mouse liver S9 fraction. Nuclear medicine and biology 20060201
Hepatic metabolism of two alpha-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human. European journal of drug metabolism and pharmacokinetics 20060101
Synthesis of potent and selective serotonin 5-HT1B receptor ligands. Bioorganic & medicinal chemistry letters 20051101
[A study of physicochemical properties of 2-, 3-, 4-alkoxyphenylcarbamic acid derivatives with a substituted N-phenylpiperazine moiety in the basic part]. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20050901
Electrospray ionization mass and tandem mass spectra of a series of N-pyrazolylmethyl and N-triazolylmethyl N-phenylpiperazines: new dopaminergic ligands with potential antipsychotic properties. Journal of mass spectrometry : JMS 20050601
Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys. Drug and alcohol dependence 20050214
Fluorous reagents and scavengers versus solid-supported reagents and scavengers, a reaction rate and kinetic comparison. Molecular diversity 20050101
Acute psychosis following ingestion of 'Rapture'. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20041201
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry. Therapeutic drug monitoring 20040801
Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles. Archiv der Pharmazie 20040701
Discovery of a potent and selective alpha v beta 3 integrin antagonist with strong inhibitory activity against neointima formation in rat balloon injury model. Bioorganic & medicinal chemistry letters 20040517
Synthesis and serotonergic activity of variously substituted (3-amido)phenylpiperazine derivatives and benzothiophene-4-piperazine derivatives: novel antagonists for the vascular 5-HT1B receptor. European journal of medicinal chemistry 20040401
Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion. Bioorganic & medicinal chemistry 20040315
Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasma. Journal of pharmaceutical and biomedical analysis 20031204
Dopaminergic profile of new heterocyclic N-phenylpiperazine derivatives. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20030501
Quantitative structure-activity relationship study of novel alpha1a-selective adrenoceptor antagonists. Journal of enzyme inhibition 20011001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2). Bioorganic & medicinal chemistry letters 20010723
Properties